Pierce Capital Research

Pierce Capital Research

Home
Archive
Leaderboard
About

New Platform. New Tools. Same Mission.

Transition to PCR, Premium Services, & Discount to Our Subscriber Base.
READ THE LATEST
Coherus Oncology (CHRS) Nasdaq Compliance Warning – Summary & Outlook
Taking a Look at Coherus Oncology's Recent Deficiency Notice.
 • 
Steve Wagner
7 Days On Us, AST SpaceMobile Clears Its Orbit, Lemonade Pulls Reinsurance Back In
Taking a Look at AST SpaceMobile (ASTS), Lemonade (LMND), & Our Free Trial.
 • 
Steve Wagner
Tesla’s Robotaxi Milestone & Biotech’s Big Opportunity
Taking a Look at Tesla (TSLA) & Biotech (XBI).
 • 
Steve Wagner
Connecting the Dots: AST SpaceMobile’s Global Momentum Just Accelerated
Taking a Look at AST SpaceMobile's (ASTS) Progress.
 • 
Steve Wagner
Lockheed’s F-35 Under Fire: Budget Cuts & Ballooning Costs
Taking a Look at Lockheed Martin's (LMT) F-35 Program.
 • 
Steve Wagner
Discounted Assets, Premium Potential: The Case for Coherus Oncology
Taking a Look at Coherus Oncology (CHRS), Special Situation Arbitrage Idea.
 • 
Steve Wagner
Tesla’s Robotaxi Reality & dLocal’s $150M Leap
Taking a Look at Tesla (TSLA) vs. Uber/Waymo & dLocal's (DLO) Acquisition.
 • 
Steve Wagner
Pierce Capital Research
Pierce Capital Research
Pierce Capital Research specializes in delivering actionable equities research on micro/small- to mega-cap companies across diverse sectors.
Recommendations
Invest in Quality
Invest in Quality
Invest In Assets 📈
Parsers Venture Capital Insights
Parsers Venture Capital Insights
Parsers VC
User's avatar
Sharp Invest Substack
Sharp Invest
From 0 to 1 in the Stock Market
From 0 to 1 in the Stock Market
Giuliano
The Profit Zone
The Profit Zone
Dividend Dominator

Pierce Capital Research

AboutArchiveRecommendationsSitemap
© 2025 Pierce Capital Research
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture